Therefore, PSMA PET/CT can be used as a complementary modality to conventional imaging for characterizing lesions, staging and/or re-staging HCC, and assessing treatment response when conventional imaging results are unclear, thereby contributing to early diagnosis and improved HCC treatment (47). Here, FOLH1 is linked to hepatocellular carcinoma.